About
Leadership
Board of Directors
Advisory Board
Strategic Partners
Platform
DELigase
Targeted Protein Modulation
Targeted Protein Degradation
Targeted Protein Elevation
Degrader-Antibody Conjugates
Pipeline
Pipeline
Hematology-Oncology
Immuno-Oncology
Inflammation
Scientific Resources
Posters & Presentations
Publications
Videos
Mechanisms of Action
Clinical Resources
Clinical Trials
Expanded Access Policy
Investors
Overview
News & Events
Financial Information
Stock Information
Corporate Governance
FAQs
Careers & Culture
Job Openings
Contact
NX-5948: BTK Degrader with Activity in Lymphoid Malignancies
Presentations
NX-5948: BTK Degrader with Activity in Lymphoid Malignancies
MENU
'
About
Leadership
Board of Directors
Advisory Board
Strategic Partners
Platform
DELigase
Targeted Protein Modulation
Targeted Protein Degradation
Targeted Protein Elevation
Degrader-Antibody Conjugates
Pipeline
Pipeline
Hematology-Oncology
Immuno-Oncology
Inflammation
Scientific Resources
Posters & Presentations
Publications
Videos
Mechanisms of Action
Clinical Resources
Clinical Trials
Expanded Access Policy
Investors
Overview
News & Events
Financial Information
Stock Information
Corporate Governance
FAQs
Careers & Culture
Job Openings
Contact
'
'
'